{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:44:49Z","timestamp":1792525489962,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","award":["P20GM130423"],"award-info":[{"award-number":["P20GM130423"]}],"id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM130423"],"award-info":[{"award-number":["P20GM130423"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","award":["BCRF SPEC-2023"],"award-info":[{"award-number":["BCRF SPEC-2023"]}],"id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","award":["BCRF SPEC-2024"],"award-info":[{"award-number":["BCRF SPEC-2024"]}],"id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007859","name":"University of Kansas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007859","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013748","name":"Hope Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U10CA180888"],"award-info":[{"award-number":["U10CA180888"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA168524"],"award-info":[{"award-number":["P30 CA168524"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U24CA196175"],"award-info":[{"award-number":["U24CA196175"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U10CA180819"],"award-info":[{"award-number":["U10CA180819"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010400","name":"Children's Mercy Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010400","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annalsofoncology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.annonc.2026.05.697","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T20:25:12Z","timestamp":1784924712000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER)"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3113-7902","authenticated-orcid":false,"given":"K.","family":"Kalinsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.E.","family":"Barlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.B.","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0570-7350","authenticated-orcid":false,"given":"R.V.","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Home","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gralow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.S.","family":"Albain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3620-7575","authenticated-orcid":false,"given":"D.F.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2106-9165","authenticated-orcid":false,"given":"S.","family":"Delaloge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.U.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.A.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.J.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.K.L.","family":"Chia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Rastogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9951-7269","authenticated-orcid":false,"given":"A.F.","family":"Schott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0881-9371","authenticated-orcid":false,"given":"E.","family":"Brain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2863-9995","authenticated-orcid":false,"given":"J.-Y.","family":"Pierga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-M.","family":"Ferrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Shak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Tripathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4873-4412","authenticated-orcid":false,"given":"G.N.","family":"Hortobagyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Meric-Bernstam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8592-2239","authenticated-orcid":false,"given":"P.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Pusztai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.K.","family":"Godwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.annonc.2026.05.697_bib1","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","article-title":"21-Gene assay to inform chemotherapy benefit in node-positive breast cancer","volume":"385","author":"Kalinsky","year":"2021","journal-title":"N Engl J Med"},{"issue":"9036","key":"10.1016\/j.annonc.2026.05.697_bib2","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0140-6736(96)05023-4","article-title":"Ovarian ablation in early breast cancer: overview of the randomised trials","volume":"348","year":"1996","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.annonc.2026.05.697_bib3","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0959-8049(97)10036-3","article-title":"Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the international Breast Cancer Study Group (IBCSG) trial VI","volume":"34","author":"Pagani","year":"1998","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.annonc.2026.05.697_bib4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/humupd\/dmac045","article-title":"Anti-M\u00fcllerian hormone for the diagnosis and prediction of menopause: a systematic review","volume":"29","author":"Nelson","year":"2023","journal-title":"Hum Reprod Update"},{"issue":"1","key":"10.1016\/j.annonc.2026.05.697_bib5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10815-019-01622-7","article-title":"The role of anti-M\u00fcllerian hormone (AMH) in ovarian disease and infertility","volume":"37","author":"Bedenk","year":"2020","journal-title":"J Assist Reprod Genet"},{"issue":"11","key":"10.1016\/j.annonc.2026.05.697_bib6","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1210\/clinem\/dgaa513","article-title":"Anti-M\u00fcllerian hormone and ovarian reserve: update on assessing ovarian function","volume":"105","author":"Moolhuijsen","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.annonc.2026.05.697_bib7","article-title":"Anti-Mullerian hormone as a marker of ovarian reserve and function","volume":"14","author":"Sinha","year":"2022","journal-title":"Cureus"},{"issue":"11","key":"10.1016\/j.annonc.2026.05.697_bib8","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/j.1600-0412.2012.01471.x","article-title":"The role of anti-Mullerian hormone in female fertility and infertility \u2013 an overview","volume":"91","author":"Grynnerup","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.annonc.2026.05.697_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.733731","article-title":"Role of AMH in prediction of menopause","volume":"12","author":"de Kat","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"10.1016\/j.annonc.2026.05.697_bib10","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1210\/jc.2011-3032","article-title":"Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women","volume":"97","author":"Freeman","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.annonc.2026.05.697_bib11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/humupd\/dmh057","article-title":"Inhibins in female and male reproductive physiology: role in gametogenesis, conception, implantation and early pregnancy","volume":"11","author":"Luisi","year":"2005","journal-title":"Hum Reprod Update"},{"issue":"4","key":"10.1016\/j.annonc.2026.05.697_bib12","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.fertnstert.2011.07.1102","article-title":"Comparisons of inhibin B versus antim\u00fcllerian hormone in poor ovarian responders undergoing in vitro fertilization","volume":"96","author":"Tan","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.annonc.2026.05.697_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.626534","article-title":"Can inhibin B reflect ovarian reserve of healthy reproductive age women effectively?","volume":"12","author":"Wen","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.annonc.2026.05.697_bib14","first-page":"123","article-title":"Inhibins in female and male reproductive physiology: role in gametogenesis, conception, implantation and early pregnancy","volume":"11","author":"Luisi","year":"2005","journal-title":"Hum Reprod"},{"issue":"9","key":"10.1016\/j.annonc.2026.05.697_bib15","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1210\/jc.2008-0567","article-title":"Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition","volume":"93","author":"Sowers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.annonc.2026.05.697_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tem.2007.01.004","article-title":"Female reproductive ageing: current knowledge and future trends","volume":"18","author":"Broekmans","year":"2007","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.annonc.2026.05.697_bib35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol"},{"issue":"12","key":"10.1016\/j.annonc.2026.05.697_bib17","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1093\/humrep\/del291","article-title":"Serum anti-Mullerian hormone throughout the human menstrual cycle","volume":"21","author":"La Marca","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.annonc.2026.05.697_bib18","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1177\/1933719115618284","article-title":"Usefulness of the ultrasensitive anti-M\u00fcllerian hormone assay for predicting true ovarian reserve","volume":"23","author":"Iwase","year":"2016","journal-title":"Reprod Sci"},{"issue":"16","key":"10.1016\/j.annonc.2026.05.697_bib19","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1016\/j.ejca.2013.07.014","article-title":"Pretreatment anti-M\u00fcllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer","volume":"49","author":"Anderson","year":"2013","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.annonc.2026.05.697_bib20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/humupd\/dmac004","article-title":"Anti-M\u00fcllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review","volume":"28","author":"Anderson","year":"2022","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.annonc.2026.05.697_bib21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejca.2017.10.001","article-title":"The utility of anti-Mullerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer","volume":"87","author":"Anderson","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.annonc.2026.05.697_bib22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejca.2021.04.038","article-title":"Chemotherapy-induced ovarian failure in young women with early breast cancer: prospective analysis of four randomised neoadjuvant\/adjuvant breast cancer trials","volume":"152","author":"Furlanetto","year":"2021","journal-title":"Eur J Cancer"},{"issue":"22","key":"10.1016\/j.annonc.2026.05.697_bib23","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMoa0909638","article-title":"Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer","volume":"362","author":"Swain","year":"2010","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.annonc.2026.05.697_bib24","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/annonc\/mdw286","article-title":"Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers","volume":"27","author":"Fumagalli","year":"2016","journal-title":"Ann Oncol"},{"issue":"suppl 16","key":"10.1016\/j.annonc.2026.05.697_bib25","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1200\/JCO.2023.41.16_suppl.504","article-title":"Evaluation of PAM50 intrinsic subtypes and risk of recurrence (ROR) scores in premenopausal women with early-stage HR+ breast cancer: a secondary analysis of the SOFT trial","volume":"41","author":"Brown","year":"2023","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.annonc.2026.05.697_bib26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41523-022-00492-0","article-title":"Molecular differences between younger versus older ER-positive and HER2-negative breast cancers","volume":"8","author":"Qing","year":"2022","journal-title":"NPJ Breast Cancer"},{"issue":"suppl 16","key":"10.1016\/j.annonc.2026.05.697_bib27","article-title":"A phase III trial evaluating addition of adjuvant chemotherapy to ovarian function suppression + endocrine therapy in premenopausal women with pN0-1, HR+\/HER2\u2212 breast cancer (BC) and oncotype recurrence score (RS) \u226425 (OFSET): NRG-BR009","volume":"43","author":"Mamounas","year":"2025","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.annonc.2026.05.697_bib28","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/annonc\/mdn037","article-title":"Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?","volume":"19","author":"Regan","year":"2008","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.annonc.2026.05.697_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10549-008-9912-9","article-title":"Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93","volume":"113","author":"Th\u00fcrlimann","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"23","key":"10.1016\/j.annonc.2026.05.697_bib30","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1002\/cncr.28942","article-title":"Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients","volume":"120","author":"Su","year":"2014","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.annonc.2026.05.697_bib31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1634\/theoncologist.2013-0145","article-title":"Prediction of postchemotherapy ovarian function using markers of ovarian reserve","volume":"19","author":"Henry","year":"2013","journal-title":"Oncologist"},{"issue":"14","key":"10.1016\/j.annonc.2026.05.697_bib32","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.ejca.2014.06.011","article-title":"A highly-sensitive anti-M \u00fc llerian hormone assay improves analysis of ovarian function following chemotherapy for early breast cancer","volume":"50","author":"Chai","year":"2014","journal-title":"Eur J Cancer"},{"issue":"25","key":"10.1016\/j.annonc.2026.05.697_bib33","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa1904819","article-title":"Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer","volume":"380","author":"Sparano","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.annonc.2026.05.697_bib34","first-page":"17","article-title":"Polycystic ovary syndrome (PCOS), diagnostic criteria, and AMH","volume":"18","author":"Bani Mohammad","year":"2017","journal-title":"Asian Pac J Cancer Prev"}],"updated-by":[{"DOI":"10.1016\/j.annonc.2026.09.013","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000}}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753426008811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753426008811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T19:44:51Z","timestamp":1785008691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753426008811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":35,"alternative-id":["S0923753426008811"],"URL":"https:\/\/doi.org\/10.1016\/j.annonc.2026.05.697","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER)","name":"articletitle","label":"Article Title"},{"value":"Annals of Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annonc.2026.05.697","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society for Medical Oncology. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}